adcwang.bsky.social
@adcwang.bsky.social
Reposted
New Publication Alert: "Fundamental properties and principal areas of focus in antibody–drug conjugates formulation development" from WuXi XDC.
academic.oup.com/abt/article/...
#Antibody #Therapeutics #ADC #Formulation
Fundamental properties and principal areas of focus in antibody–drug conjugates formulation development
Statement of Significance: This article comprehensively reviews and summarizes the formulations of commercial antibody–drug conjugates (ADCs) for the first
academic.oup.com
June 13, 2025 at 2:12 PM
Reposted
New Publication Alert: "A systematic review of the avian antibody (IgY) therapeutic effects on human bacterial infections over the decade" contributed from Mashhad University of Medical Sciences.
Free access of the full text article through academic.oup.com/abt/article/...
#Antibody #Therapeutics
A systematic review of the avian antibody (IgY) therapeutic effects on human bacterial infections over the decade
Statement of Significance: The dose-dependent therapeutic effects of antibody have been reported in the treatment of some infections include: oral, skin, g
academic.oup.com
June 16, 2025 at 10:54 PM
Reposted
New Publication Alert: "Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors" from Chinese Academy of Sciences.
Free Access of Full text article through: academic.oup.com/abt/article/...
#Antibody #Therapeutics #ADC #mAbs
Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors
Statement of significance Many ADCs have unacceptable toxic effects, slowing their development progress. We describe the effects of ADC molecule structures
academic.oup.com
June 17, 2025 at 10:14 PM
Reposted
New Publication Alert: "Structure and function of therapeutic antibodies approved by the US FDA in 2024" from William R Strohl.
academic.oup.com/abt/advance-...
#Antibody #Therapeutics #FDA #mAbs
Structure and function of therapeutic antibodies approved by the US FDA in 2024
Abstract. In 2024, the FDA approved 47 new molecular entities (NMEs), including 15 therapeutic antibody-based molecules, marking the 30th anniversary of th
academic.oup.com
July 1, 2025 at 12:27 AM
Reposted
New Publication Alert: “Matching placebo development for injectable biologics—a practical tutorial” contributed by Yunsong Li from WuXi Biologics.
Free access to the article through academic.oup.com/abt/advance-...
#Antibody #Therapeutics #mAbs
Matching placebo development for injectable biologics—a practical tutorial
AbstractBackground. In drug development, placebo-controlled trials are vital for assessing treatment efficacy. Developing a suitable placebo for injectable
academic.oup.com
June 3, 2025 at 11:14 AM
Reposted
New CiteScore Release: Antibody Therapeutics, published by Oxford University Press, is thrilled to announce that the newest CiteScore 2024 is 8.4. Thanks all the support from our readers, reviewers, editors, and editorial board members!
June 3, 2025 at 10:31 PM
Reposted
New Publication Alert: "A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy" from Convalife Pharmaceuticals.
Free access of full text article through:https://academic.oup.com/abt/advance-article/doi/10.1093/abt/tbaf012/8140624
#Antibody #mAbs
June 4, 2025 at 11:22 AM
Reposted
As a peer-reviewed and open access journal published by Oxford University Press, Antibody Therapeutics provides a forum for latest advances and challenges of therapeutic antibodies. The journal has been indexed by ESCI, Scopus (CiteScore=8.7) and PubMed Central.
academic.oup.com/abt
#Antibody #mAbs
Antibody Therapeutics | Oxford Academic
Launching in 2018, Antibody Therapeutics will publish the latest advances and challenges in the discovery, research, development, manufacturing and methodology of therapeutic antibodies for the global...
academic.oup.com
June 2, 2025 at 10:16 PM